查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1599203

全球血管支架市場：按類型、材料、輸送方式、產品、最終用戶分類 - 預測 2025-2030

Vascular Stent Market by Type (Bare Metal Stent, Bio-Engineered Stent, Drug Eluting Stent), Material (Metallic Stent, Polymer), Mode of Delivery, Product, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年血管支架市值為213.4億美元，預計2024年將達到241.3億美元，複合年成長率為13.54%，2030年將達519.3億美元。

血管支架市場包括用於治療血管狹窄或閉塞的醫療設備的開發和分銷。這些支架對於心血管疾病的治療至關重要，為開放動脈和靜脈提供必要的支持，以確保正常的血液流動。由於生活方式的改變和老化，冠狀動脈疾病和周邊動脈疾病不斷增加，血管支架在醫療過程中的應用變得越來越重要。最終用途部分主要包括醫院、門診手術中心、心臟專科中心等，微創手術的進步進一步推動了市場需求。

主要市場統計
基準年[2023] 213.4億美元
預測年份 [2024] 241.3億美元
預測年份 [2030] 519.3億美元
複合年成長率（%） 13.54%

影響該市場的關鍵成長要素包括支架設計的技術進步，例如藥物釋放型支架，它可以透過降低血管再阻塞率來改善患者的治療效果。此外，生物可吸收和完全可分解支架技術的整合代表了未來創新的潛力。與文明病盛行率不斷上升、醫療保健支出不斷增加以及對血管併發症早期療育的意識不斷增強，進一步推動了市場需求。然而，與先進支架技術相關的限制，例如高成本、監管障礙以及支架血栓症等潛在併發症，對市場成長構成了挑戰。

創新機會在於生物分解性支架的開發以及人工智慧的整合以實現個人化治療計劃和改善病患監測。一個重要的研究領域是提高支架的生物相容性和功能性，以滿足不同患者的需求。作為一個競爭激烈的市場，保持領先地位和市場相關性需要持續研究，並專注於新材料開發和非侵入性治療方法。公司應致力於利用策略夥伴關係關係並投資於研發，以提高產品多樣化和市場滲透率。解決負擔能力問題並確保有利的報銷政策對於促進更廣泛的採用也至關重要，特別是在醫療基礎設施正在發展的新興市場。

市場動態：揭示快速發展的血管支架市場的關鍵市場洞察

供需的動態交互作用正在改變血管支架市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 血管疾病盛行率增加和老年人口增加
    • 隨著健康保險覆蓋範圍的擴大，手術變得越來越容易。
    • 對微創醫療程序的需求不斷成長
  • 市場限制因素
    • 替代藥物的可用性和產品召回
  • 市場機會
    • 生物可吸收支架的開發日益受到關注
    • 增加聯合策略舉措以擴大業務
  • 市場挑戰
    • 與支架置入相關的併發症

波特五力：駕馭血管支架市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解血管支架市場的外部影響

外部宏觀環境因素對血管支架市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解血管支架市場的競爭格局

血管支架市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣血管支架市場供應商的績效評估

FPNV定位矩陣是評估血管支架市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了血管支架市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對血管支架市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 血管疾病盛行率增加和老年人口增加
      • 健康保險覆蓋範圍將擴大，使外科手術變得更加容易。
      • 對微創醫療程序的需求增加
    • 抑制因素
      • 替代醫學的可用性和產品召回
    • 機會
      • 生物可吸收支架的發展越來越受到人們的關注。
      • 加強業務擴展的聯合策略舉措
    • 任務
      • 與支架置入相關的併發症
  • 市場區隔分析
    • 最終用戶：在門診手術中心採用血管支架以獲得高品質護理和快速康復
    • 產品：利用髂支架預防跛行、肢體缺血等併發症
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章血管支架市場：依類型

  • 裸金屬支架
  • 生物工程支架
  • 藥物釋放型支架
  • 雙治療支架

第7章血管支架市場：依材料分類

  • 金屬支架
  • 聚合物

第8章以輸送方式分類的血管支架市場

  • 球囊擴張型支架
  • 自動擴張型支架

第9章血管支架市場：依產品

  • 冠狀動脈支架
  • 周邊血管支架
    • 腹部主動脈血管瘤
    • 胸主動脈瘤
  • 外周支架
    • 頸動脈支架
    • 股骨支架
    • 髂支架
    • 腎動脈支架

第10章血管支架市場：依最終用戶分類

  • 門診手術中心
  • 心臟中心
  • 醫院

第11章 北美、南美血管支架市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太血管支架市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲血管支架市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 波士頓科學透過收購 Silk Road Medical 加強血管產品組合和長期成長
    • Abbott 推出 Xience Sierra 冠狀動脈支架系統，以加強對心臟病患者的護理
    • SMT 與 HeartX 之間的策略合作徹底改變了全球先天性心臟疾病的治療
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Biosensors International Group, Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cook Medical, Inc
  • CryoLife, Inc.
  • Elixir Medical Corporation
  • Endologix, Inc.
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd
  • Microport Scientific Corporation
  • Purple Medical Solution Pvt. Ltd
  • Sahajanand Medical Technologies Pvt. Ltd
  • Stryker Corporation
  • Terumo Corporation
  • Veryan Medical Limited.
  • WL Gore & Associates, Inc.
Product Code: MRR-034B5003037F

The Vascular Stent Market was valued at USD 21.34 billion in 2023, expected to reach USD 24.13 billion in 2024, and is projected to grow at a CAGR of 13.54%, to USD 51.93 billion by 2030.

The vascular stent market encompasses the development and distribution of medical devices used to treat narrowed or blocked blood vessels. These stents are critical in managing cardiovascular diseases, offering essential support to open arteries and veins, thus ensuring proper blood flow. With increasing instances of coronary artery disease and peripheral artery disease, driven by lifestyle changes and growing aging populations, the application of vascular stents in medical procedures becomes crucial. End-use sectors primarily include hospitals, ambulatory surgical centers, and specialized cardiac centers, with a significant impetus from advancements in minimally invasive procedures further driving market demand.

KEY MARKET STATISTICS
Base Year [2023] USD 21.34 billion
Estimated Year [2024] USD 24.13 billion
Forecast Year [2030] USD 51.93 billion
CAGR (%) 13.54%

Key growth factors influencing this market include technological advancements in stent design, such as drug-eluting stents, which enhance patient outcomes by reducing restenosis rates. Additionally, the integration of bioresorbable and fully degradable stent technologies showcases potential opportunities for future innovation. The increasing prevalence of lifestyle disorders, coupled with rising healthcare expenditures and awareness regarding early intervention in vascular complications, further propels market demand. However, limitations such as high costs associated with advanced stent technologies, regulatory hurdles, and potential complications such as stent thrombosis present challenges to market growth.

Innovation opportunities lie in developing biodegradable stents and integrating artificial intelligence for personalized treatment planning and improved patient monitoring. A key area for research is enhancing the biocompatibility and functionality of stents to cater to diverse patient needs. The competitive nature of the market necessitates continuous research, focusing on new material development and non-invasive treatment methods to maintain leadership and market relevance. Companies should aim to leverage strategic partnerships and investments in R&D for product diversification and to enhance market penetration. Addressing affordability and securing favorable reimbursement policies will also be vital to fostering broader adoption, especially in emerging markets with growing healthcare infrastructures.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vascular Stent Market

The Vascular Stent Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of vascular diseases and growth in geriatric population
    • Expanding health insurance coverage makes surgical procedures more accessible,
    • Rising demand for minimally invasive medical procedures
  • Market Restraints
    • Availability of alternative medical treatments and product recalls
  • Market Opportunities
    • Rising focus on bioresorbable stents developments
    • Increasing collaborative strategic initiatives for business expansion
  • Market Challenges
    • Complications associated with the stent implementation

Porter's Five Forces: A Strategic Tool for Navigating the Vascular Stent Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vascular Stent Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vascular Stent Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vascular Stent Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vascular Stent Market

A detailed market share analysis in the Vascular Stent Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vascular Stent Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vascular Stent Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vascular Stent Market

A strategic analysis of the Vascular Stent Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vascular Stent Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, Biosensors International Group, Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Medical, Inc, CryoLife, Inc., Elixir Medical Corporation, Endologix, Inc., Medtronic PLC, Meril Life Sciences Pvt. Ltd, Microport Scientific Corporation, Purple Medical Solution Pvt. Ltd, Sahajanand Medical Technologies Pvt. Ltd, Stryker Corporation, Terumo Corporation, Veryan Medical Limited., and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Vascular Stent Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Bare Metal Stent, Bio-Engineered Stent, Drug Eluting Stent, and Dual Therapy Stent.
  • Based on Material, market is studied across Metallic Stent and Polymer.
  • Based on Mode of Delivery, market is studied across Balloon-Expandable Stent and Self-Expanding Stent.
  • Based on Product, market is studied across Coronary Stent, Evar Stent Graft, and Peripheral Stent. The Evar Stent Graft is further studied across Abdominal Aortic Aneurysm and Thoracic Aortic Aneurysm. The Peripheral Stent is further studied across Carotid Stent, Femoral Stent, Iliac Stent, and Renal Artery Stent.
  • Based on End-User, market is studied across Ambulatory Surgical Center, Cardiac Center, and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of vascular diseases and growth in geriatric population
      • 5.1.1.2. Expanding health insurance coverage makes surgical procedures more accessible,
      • 5.1.1.3. Rising demand for minimally invasive medical procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of alternative medical treatments and product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising focus on bioresorbable stents developments
      • 5.1.3.2. Increasing collaborative strategic initiatives for business expansion
    • 5.1.4. Challenges
      • 5.1.4.1. Complications associated with the stent implementation
  • 5.2. Market Segmentation Analysis
    • 5.2.1. End-Users: Adoption of vascular stent in ambulatory surgical centers for high-quality care and rapid recovery
    • 5.2.2. Product: Utilisation of iliac stents for prevention of complications such as claudication and limb ischemia
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vascular Stent Market, by Type

  • 6.1. Introduction
  • 6.2. Bare Metal Stent
  • 6.3. Bio-Engineered Stent
  • 6.4. Drug Eluting Stent
  • 6.5. Dual Therapy Stent

7. Vascular Stent Market, by Material

  • 7.1. Introduction
  • 7.2. Metallic Stent
  • 7.3. Polymer

8. Vascular Stent Market, by Mode of Delivery

  • 8.1. Introduction
  • 8.2. Balloon-Expandable Stent
  • 8.3. Self-Expanding Stent

9. Vascular Stent Market, by Product

  • 9.1. Introduction
  • 9.2. Coronary Stent
  • 9.3. Evar Stent Graft
    • 9.3.1. Abdominal Aortic Aneurysm
    • 9.3.2. Thoracic Aortic Aneurysm
  • 9.4. Peripheral Stent
    • 9.4.1. Carotid Stent
    • 9.4.2. Femoral Stent
    • 9.4.3. Iliac Stent
    • 9.4.4. Renal Artery Stent

10. Vascular Stent Market, by End-User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Center
  • 10.3. Cardiac Center
  • 10.4. Hospital

11. Americas Vascular Stent Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Vascular Stent Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Vascular Stent Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Boston Scientific to boost vascular portfolio and long-term growth with Silk Road Medical acquisition
    • 14.3.2. Abbott introduces Xience Sierra coronary stent system for enhanced heart patient care
    • 14.3.3. Strategic partnership between SMT and HeartX to revolutionize congenital heart defect treatment worldwide
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. B. Braun Melsungen AG
  • 3. Becton, Dickinson and Company
  • 4. Biosensors International Group, Ltd.
  • 5. Biotronik SE & Co. KG
  • 6. Boston Scientific Corporation
  • 7. Cook Medical, Inc
  • 8. CryoLife, Inc.
  • 9. Elixir Medical Corporation
  • 10. Endologix, Inc.
  • 11. Medtronic PLC
  • 12. Meril Life Sciences Pvt. Ltd
  • 13. Microport Scientific Corporation
  • 14. Purple Medical Solution Pvt. Ltd
  • 15. Sahajanand Medical Technologies Pvt. Ltd
  • 16. Stryker Corporation
  • 17. Terumo Corporation
  • 18. Veryan Medical Limited.
  • 19. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. VASCULAR STENT MARKET RESEARCH PROCESS
  • FIGURE 2. VASCULAR STENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VASCULAR STENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VASCULAR STENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VASCULAR STENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VASCULAR STENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VASCULAR STENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL VASCULAR STENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL VASCULAR STENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL VASCULAR STENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES VASCULAR STENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES VASCULAR STENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. VASCULAR STENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. VASCULAR STENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VASCULAR STENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VASCULAR STENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VASCULAR STENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VASCULAR STENT MARKET DYNAMICS
  • TABLE 7. GLOBAL VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VASCULAR STENT MARKET SIZE, BY BARE METAL STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VASCULAR STENT MARKET SIZE, BY BIO-ENGINEERED STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VASCULAR STENT MARKET SIZE, BY DRUG ELUTING STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VASCULAR STENT MARKET SIZE, BY DUAL THERAPY STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VASCULAR STENT MARKET SIZE, BY METALLIC STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VASCULAR STENT MARKET SIZE, BY POLYMER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VASCULAR STENT MARKET SIZE, BY BALLOON-EXPANDABLE STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VASCULAR STENT MARKET SIZE, BY SELF-EXPANDING STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VASCULAR STENT MARKET SIZE, BY CORONARY STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VASCULAR STENT MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL VASCULAR STENT MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL VASCULAR STENT MARKET SIZE, BY CAROTID STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL VASCULAR STENT MARKET SIZE, BY FEMORAL STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL VASCULAR STENT MARKET SIZE, BY ILIAC STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL VASCULAR STENT MARKET SIZE, BY RENAL ARTERY STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL VASCULAR STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL VASCULAR STENT MARKET SIZE, BY CARDIAC CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL VASCULAR STENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES VASCULAR STENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 311. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 325. VASCULAR STENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 326. VASCULAR STENT MARKET, FPNV POSITIONING MATRIX, 2023